Condition

Treatment Strategy (2)

Autologous Stem Cell Transplantation (1)

Cyclophosphamide (1)

Mycophenolate Mofetil (1)

Scleroderma (1)

Scleroderma, Diffuse (1)

Systemic Scleroses, Diffuse (1)

Systemic Sclerosis (1)

Unruptured Cerebral Aneurysm (1)

Overall Status

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Changhai Hospital (1)

UMC Utrecht (1)

Collaborator

Boehringer Ingelheim (1)

Miltenyi Biotec, Inc. (1)

ZonMw: The Netherlands Organisation for Health Research and Development (1)

Intervention

upfront autologous hsct (1)

Study Documents

Intervention Type

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

treatment strategy

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Systemic Sclerosis, Systemic Scleroses, Diffuse, Scleroderma Trial in Worldwide (Upfront autologous HSCT)

Recruiting

Systemic Sclerosis
+7 more

Upfront autologous HSCT

Ghent, Belgium
+13 more

Nov 25, 2021

New Therapeutic System of Unruptured Intracranial Aneurysms

Unknown status

Unruptured Cerebral Aneurysm
Treatment Strategy

Shanghai, Shanghai, China

Changhai Hospital

May 12, 2017